Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TPTX

Turning Point Therapeutics (TPTX) Stock Price, News & Analysis

Turning Point Therapeutics logo

About Turning Point Therapeutics Stock (NASDAQ:TPTX)

Advanced Chart

Key Stats

Today's Range
$76.01
$76.01
50-Day Range
$74.80
$76.01
52-Week Range
$23.77
$82.20
Volume
4,322 shs
Average Volume
1.14 million shs
Market Capitalization
$3.81 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TPTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Turning Point Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TPTX Stock News Headlines

Turning Point of Tampa Now In-Network with Blue Cross Blue Shield Insurance
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
Turning Point Brands Inc.
Alzheimer’s: A Turning Point?
See More Headlines

TPTX Stock Analysis - Frequently Asked Questions

Turning Point Therapeutics, Inc. (NASDAQ:TPTX) issued its quarterly earnings results on Tuesday, November, 9th. The company reported ($1.34) EPS for the quarter, missing the consensus estimate of ($1.26) by $0.08. The company earned $0.46 million during the quarter.

Turning Point Therapeutics (TPTX) raised $167 million in an initial public offering on Wednesday, April 17th 2019. The company issued 9,300,000 shares at a price of $18.00 per share. Goldman Sachs, SVB Leerink and Wells Fargo Securities acted as the underwriters for the IPO and Canaccord Genuity was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Turning Point Therapeutics investors own include Meta Platforms (META), Diamondback Energy (FANG), Gilead Sciences (GILD), HubSpot (HUBS), Netflix (NFLX), NVIDIA (NVDA) and Pfizer (PFE).

Company Calendar

Last Earnings
11/09/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TPTX
CIK
1595893
Fax
N/A
Employees
250
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.90)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$236.55 million
Net Margins
N/A
Pretax Margin
-33,959.03%
Return on Equity
-37.45%
Return on Assets
-35.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
16.83
Quick Ratio
16.83

Sales & Book Value

Annual Sales
$30.83 million
Price / Sales
123.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.84 per share
Price / Book
4.80

Miscellaneous

Outstanding Shares
50,074,000
Free Float
45,768,000
Market Cap
$3.81 billion
Optionable
Not Optionable
Beta
-0.18
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:TPTX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners